Favorable outcome of severe, extensive, granulocyte colony-stimulating factor-induced, corticosteroid-resistant Sweet's syndrome treated with high-dose intravenous immunoglobulin.

MLA

Calixto, Rodolfo, et al. “Favorable Outcome of Severe, Extensive, Granulocyte Colony-Stimulating Factor-Induced, Corticosteroid-Resistant Sweet’s Syndrome Treated with High-Dose Intravenous Immunoglobulin.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 32, no. 5, Feb. 2014, pp. e1–2. EBSCOhost, https://doi.org/10.1200/JCO.2011.40.3212.

APA

Calixto, R., Menezes, Y., Ostronoff, M., Sucupira, A., Botelho, L. F., Florencio, R., Martins, M., & Souto Maior, A. P. (2014). Favorable outcome of severe, extensive, granulocyte colony-stimulating factor-induced, corticosteroid-resistant Sweet’s syndrome treated with high-dose intravenous immunoglobulin. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 32(5), e1–e2. https://doi.org/10.1200/JCO.2011.40.3212

Chicago

Calixto, Rodolfo, Yara Menezes, Maurício Ostronoff, Alexandre Sucupira, Luis Fábio Botelho, Rodrigo Florencio, Monique Martins, and Ana Patrícia Souto Maior. 2014. “Favorable Outcome of Severe, Extensive, Granulocyte Colony-Stimulating Factor-Induced, Corticosteroid-Resistant Sweet’s Syndrome Treated with High-Dose Intravenous Immunoglobulin.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 32 (5): e1–2. doi:10.1200/JCO.2011.40.3212.